Dysbiosis‐induced intestinal inflammation activates tumor necrosis factor receptor I and mediates alcoholic liver disease in mice

Intestinal mucosal barrier function in health and disease

Turner, J. R. (2009) · Nature reviews. Immunology · doi:10.1038/nri2653 · Cited by 3,952 · see citing works

Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity

Henao-Mejia, J., Elinav, E., Jin, C., Hao, L., Mehal, W. Z., Strowig, T., Thaiss, C. A., Kau, A. L., Eisenbarth, S. C., Jurczak, M. J., et al. (2012) · Nature · doi:10.1038/nature10809 · Cited by 2,435 · see citing works

Interactions Between the Intestinal Microbiome and Liver Diseases

Schnabl, B., & Brenner, D. A. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.01.020 · Cited by 971 · see citing works

Enteric dysbiosis associated with a mouse model of alcoholic liver disease

Yan, A. W., Fouts, D. E., Brandl, J., Stärkel, P., Torralba, M., Schott, E., Tsukamoto, H., Nelson, K. E., Brenner, D. A., & Schnabl, B. (2011) · Hepatology · doi:10.1002/hep.24018 · Cited by 791 · see citing works

IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice

Petrasek, J., Bala, S., Csak, T., Lippai, D., Kodys, K., Menashy, V., Barrieau, M., Min, S.-Y., Kurt-Jones, E. A., & Szabo, G. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60777 · Cited by 735 · see citing works

Essential role of tumor necrosis factor α in alcohol-induced liver injury in mice

Yin, M., Wheeler, M. D., Kono, H., Bradford, B. U., Gallucci, R. M., Luster, M. I., & Thurman, R. G. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70354-9 · Cited by 699 · see citing works

Antibiotics prevent liver injury in rats following long-term exposure to ethanol

Adachi, Y., Moore, L. E., Bradford, B. U., Gao, W., & Thurman, R. G. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90027-6 · Cited by 692 · see citing works

Metagenomic Analyses of Alcohol Induced Pathogenic Alterations in the Intestinal Microbiome and the Effect of Lactobacillus rhamnosus GG Treatment

Bull–Otterson, L., Feng, W., Kirpich, I., Wang, Y., Qin, X., Liu, Y., Gobejishvili, L., Joshi‐Barve, S., Ayvaz, T., Petrosino, J. F., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053028 · Cited by 543 · see citing works

Molecular Basis of Epithelial Barrier Regulation

Turner, J. R. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.060681 · Cited by 542 · see citing works

Toll–Like Receptor 4 Is Involved in the Mechanism of Early Alcohol–Induced Liver Injury in Mice

Uesugi, T., Froh, M., Arteel, G. E., Bradford, B. U., & Thurman, R. G. (2001) · Hepatology · doi:10.1053/jhep.2001.25350 · Cited by 488 · see citing works

Caveolin-1–dependent occludin endocytosis is required for TNF-induced tight junction regulation in vivo

Marchiando, A. M., Shen, L., Graham, W. V., Weber, C. R., Schwarz, B. T., Austin, J. R., Raleigh, D. R., Guan, Y., Watson, A. J. M., Montrose, M. H., et al. (2010) · The Journal of Cell Biology · doi:10.1083/jcb.200902153 · Cited by 475 · see citing works

Targeted epithelial tight junction dysfunction causes immune activation and contributes to development of experimental colitis

Su, L., Shen, L., Clayburgh, D. R., Nalle, S. C., Sullivan, E. A., Meddings, J. B., Abraham, C., & Turner, J. R. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.10.081 · Cited by 455 · see citing works

THE LEAKY GUT OF ALCOHOLISM: POSSIBLE ROUTE OF ENTRY FOR TOXIC COMPOUNDS

Bjarnason, I., Ward, K., & Peters, T. B. (1984) · The Lancet · doi:10.1016/s0140-6736(84)92109-3 · Cited by 432 · see citing works

Epithelial myosin light chain kinase-dependent barrier dysfunction mediates T cell activation-induced diarrhea in vivo

Clayburgh, D. R. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24970 · Cited by 419 · see citing works

The critical role of toll‐like receptor (TLR) 4 in alcoholic liver disease is independent of the common TLR adapter MyD88†

Hritz, I., Mandrekar, P., Velayudham, A., Catalano, D., Dolganiuc, A., Kodys, K., Kurt‐Jones, E., & Szabo, G. (2008) · Hepatology · doi:10.1002/hep.22470 · Cited by 415 · see citing works

TNFR2 Activates MLCK-Dependent Tight Junction Dysregulation to Cause Apoptosis-Mediated Barrier Loss and Experimental Colitis

Su, L., Nalle, S. C., Shen, L., Turner, E. S., Singh, G., Breskin, L. A., Khramtsova, E. A., Khramtsova, G. F., Tsai, P., Fu, Y., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.04.011 · Cited by 393 · see citing works

A membrane-permeant peptide that inhibits MLC kinase restores barrier function in in vitro models of intestinal disease

Zolotarevsky, Y., Hecht, G. A., Koutsouris, A., Gonzalez, D. E., Quan, C., Tom, J., Mrsny, R. J., & Turner, J. R. (2002) · Gastroenterology · doi:10.1053/gast.2002.34235 · Cited by 385 · see citing works

Alcoholic liver disease and the gut-liver axis

Szabó, G. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i11.1321 · Cited by 378 · see citing works

Interleukin-10 Gene-Deficient Mice Develop a Primary Intestinal Permeability Defect in Response to Enteric Microflora

Madsen, K. L., Malfair, D., Gray, D., Doyle, J. S. G., Jewell, L. D., & Fedorak, R. N. (1999) · Inflammatory Bowel Diseases · doi:10.1097/00054725-199911000-00004 · Cited by 318 · see citing works

Exacerbation of Alcoholic Liver Injury by Enteral Endotoxin in Rats

Mathurin, P., Deng, Q.-G., Keshavarzian, A., Choudhary, S., HOLMES, E. W., & Tsukamoto, H. (2000) · Hepatology · doi:10.1053/jhep.2000.19621 · Cited by 297 · see citing works

Severity of liver injury in experimental alcoholic liver disease. Correlation with plasma endotoxin, prostaglandin E2, leukotriene B4, and thromboxane B2.

Nanji, A. A., Khettry, U., Sadrzadeh, S. M. H., & Yamanaka, T. (1993) · PubMed Central · Cited by 286 · see citing works

Ethanol modulation of intestinal epithelial tight junction barrier

Ma, T. Y., Nguyen, D., Bui, V., Nguyen, H. B., & Hoa, N. T. (1999) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1999.276.4.g965 · Cited by 261 · see citing works

Deficiency of intestinal mucin-2 ameliorates experimental alcoholic liver disease in mice

Hartmann, P., Chen, P., Wang, H. J., Wang, L., McCole, D. F., Brandl, K., Stärkel, P., Belzer, C., Hellerbrand, C., Tsukamoto, H., et al. (2013) · Hepatology · doi:10.1002/hep.26321 · Cited by 246 · see citing works

MOLECULAR REGULATION OF THE HUMAN INDUCIBLE NITRIC OXIDE SYNTHASE (iNOS) GENE

Taylor, B. S., & Geller, D. A. (2000) · Shock · doi:10.1097/00024382-200006000-00001 · Cited by 186 · see citing works

Activated intestinal macrophages in patients with cirrhosis release NO and IL-6 that may disrupt intestinal barrier function

du Plessis, J., Vanheel, H., Janssen, C., Roos, L., Slavík, T., Stivaktas, P. I., Nieuwoudt, M., van Wyk, S. G., Vieira, W. A., Pretorius, E., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.01.038 · Cited by 178 · see citing works

Role of protein tyrosine phosphorylation in acetaldehyde-induced disruption of epithelial tight junctions

Atkinson, K. J., & Rao, R. (2001) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2001.280.6.g1280 · Cited by 171 · see citing works

Amelioration of IFN-γ and TNF-α-Induced Intestinal Epithelial Barrier Dysfunction by Berberine via Suppression of MLCK-MLC Phosphorylation Signaling Pathway

Cao, M., Wang, P., Sun, C., He, W., & Wang, F. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061944 · Cited by 168 · see citing works

Ethanol-Induced Barrier Dysfunction and Its Prevention by Growth Factors in Human Intestinal Monolayers: Evidence for Oxidative and Cytoskeletal Mechanisms

Banan, A., Choudhary, S., Zhang, Y., Fields, J. Z., & Keshavarzian, A. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35212-7 · Cited by 165 · see citing works

Intestinal epithelial cells as producers but not targets of chronic TNF suffice to cause murine Crohn-like pathology

Roulis, M., Armaka, M., Manoloukos, M., Apostolaki, M., & Kollias, G. A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1007811108 · Cited by 134 · see citing works

Critical role of tumor necrosis factor receptor 1, but not 2, in hepatic stellate cell proliferation, extracellular matrix remodeling, and liver fibrogenesis

Tarrats, N., Moles, A., Morales, A., García-Ruiz, C., Fernández-Checa, J. C., & Marí, M. (2011) · Hepatology · doi:10.1002/hep.24388 · Cited by 128 · see citing works

Acetaldehyde-induced Barrier Disruption and Paracellular Permeability in Caco-2 Cell Monolayer

Rao, R. K. (2008) · Methods in molecular biology · doi:10.1007/978-1-59745-242-7_13 · Cited by 125 · see citing works

FDC-Specific Functions of p55TNFR and IKK2 in the Development of FDC Networks and of Antibody Responses

Victoratos, P., Lagnel, J., Tzima, S., Alimzhanov, M. B., Rajewsky, K., Pasparakis, M., & Kollias, G. A. (2006) · Immunity · doi:10.1016/j.immuni.2005.11.013 · Cited by 123 · see citing works

Toll-Like Receptor 2–Mediated Intestinal Injury and Enteric Tumor Necrosis Factor Receptor I Contribute to Liver Fibrosis in Mice

Hartmann, P., Haimerl, M., Mazagova, M., Brenner, D. A., & Schnabl, B. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.07.099 · Cited by 118 · see citing works

Acetaldehyde disrupts tight junctions in Caco-2 cell monolayers by a protein phosphatase 2A-dependent mechanism

Dunagan, M., Chaudhry, K., Samak, G., & Rao, R. K. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00526.2011 · Cited by 103 · see citing works

Inhibition of long myosin light-chain kinase activation alleviates intestinal damage after binge ethanol exposure and burn injury

Zahs, A., Bird, M. D., Ramírez, L., Turner, J. R., Choudhry, M. A., & Kovacs, E. J. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00157.2012 · Cited by 96 · see citing works

Inhibition of basal p38 or JNK activity enhances epithelial barrier function through differential modulation of claudin expression

Carrozzino, F., Pugnale, P., Féraille, E., & Montesano, R. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00084.2009 · Cited by 76 · see citing works

Role of Phospholipase Cγ-induced Activation of Protein Kinase Cϵ (PKCϵ) and PKCβI in Epidermal Growth Factor-mediated Protection of Tight Junctions from Acetaldehyde in Caco-2 Cell Monolayers

Suzuki, T., Seth, A., & Rao, R. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m709141200 · Cited by 75 · see citing works

ERK is involved in EGF-mediated protection of tight junctions, but not adherens junctions, in acetaldehyde-treated Caco-2 cell monolayers

Samak, G., Aggarwal, S., & Rao, R. K. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00494.2010 · Cited by 58 · see citing works

Activation of the Epithelial-to-Mesenchymal Transition Factor Snail Mediates Acetaldehyde-Induced Intestinal Epithelial Barrier Disruption

Elamin, E. E., Masclee, A., Troost, F. J., Dekker, J. P., & Jonkers, D. M. A. E. (2013) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.12234 · Cited by 36 · see citing works

The gut-liver axis in liver disease: Pathophysiological basis for therapy

Albillos, A., de Gottardi, A., & Rescigno, M. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2019.10.003 · Cited by 2,166 · see citing works

The gut-liver axis and the intersection with the microbiome

Tripathi, A., Debelius, J., Brenner, D. A., Karin, M., Loomba, R., Schnabl, B., & Knight, R. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0011-z · Cited by 1,480 · see citing works

Alcoholic liver disease: mechanisms of injury and targeted treatment

Louvet, A., & Mathurin, P. (2015) · Nature Reviews Gastroenterology &Hepatology · doi:10.1038/nrgastro.2015.35 · Cited by 820 · see citing works

Gut-liver axis: Pathophysiological concepts and clinical implications

Tilg, H., Adolph, T. E., & Trauner, M. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.09.017 · Cited by 843 · see citing works

The gut microbiome and liver cancer: mechanisms and clinical translation

Yu, L.-X., & Schwabe, R. F. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.72 · Cited by 634 · see citing works

Mechanisms of decompensation and organ failure in cirrhosis: From peripheral arterial vasodilation to systemic inflammation hypothesis

Bernardi, M., Moreau, R., Angeli, P., Schnabl, B., & Arroyo, V. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.07.004 · Cited by 633 · see citing works

Leaky Gut As a Danger Signal for Autoimmune Diseases

Mu, Q., Kirby, J. L., Reilly, C. M., & Luo, X. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00598 · Cited by 618 · see citing works

Contribution of the Intestinal Microbiome and Gut Barrier to Hepatic Disorders

Chopyk, D. M., & Grakoui, A. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.04.077 · Cited by 495 · see citing works

Intestinal fungi contribute to development of alcoholic liver disease

Yang, A., Inamine, T., Hochrath, K., Chen, P., Wang, L., Llorente, C., Bluemel, S., Hartmann, P., Xu, J., Koyama, Y., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci90562 · Cited by 465 · see citing works

Cirrhosis-associated immune dysfunction

Albillos, A., Martín‐Mateos, R., der Merwe, V., Wiest, R., Jalan, R., & Álvarez‐Mon, M. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00520-7 · Cited by 461 · see citing works

Intestinal REG3 Lectins Protect against Alcoholic Steatohepatitis by Reducing Mucosa-Associated Microbiota and Preventing Bacterial Translocation

Wang, L., Fouts, D. E., Stärkel, P., Hartmann, P., Chen, P., Llorente, C., DePew, J., Moncera, K. J., Ho, S. B., Brenner, D. A., et al. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.01.003 · Cited by 384 · see citing works

Bacteria engineered to produce IL-22 in intestine induce expression of REG3G to reduce ethanol-induced liver disease in mice

Hendrikx, T., Duan, Y., Wang, Y., Oh, J., Alexander, L. M., Huang, W. J. M., Stärkel, P., Ho, S. B., Gao, B., Fiehn, O., et al. (2018) · Gut · doi:10.1136/gutjnl-2018-317232 · Cited by 363 · see citing works

Fecal microbiota manipulation prevents dysbiosis and alcohol-induced liver injury in mice

Ferrere, G., Wrzosek, L., Cailleux, F., Turpin, W., Puchois, V., Spatz, M., Ciocan, D. M., Rainteau, D. P., Humbert, L., Hugot, C., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.11.008 · Cited by 324 · see citing works

Stress induces endotoxemia and low-grade inflammation by increasing barrier permeability

de Punder, K., & Pruimboom, L. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00223 · Cited by 321 · see citing works

Gut Microbiota Dysbiosis: Pathogenesis, Diseases, Prevention, and Therapy

Shen, Y., Fan, N., Ma, S., Cheng, X., Yang, X., & Wang, G. (2025) · MedComm · doi:10.1002/mco2.70168 · Cited by 364 · see citing works

Modulation of the intestinal bile acid/farnesoid X receptor/fibroblast growth factor 15 axis improves alcoholic liver disease in mice

Hartmann, P., Hochrath, K., Horvath, A., Chen, P., Seebauer, C. T., Llorente, C., Wang, L., Alnouti, Y., Fouts, D. E., Stärkel, P., et al. (2018) · Hepatology · doi:10.1002/hep.29676 · Cited by 290 · see citing works

Recent Advances in Understanding of Pathogenesis of Alcohol-Associated Liver Disease

Wu, X., Fan, X., Miyata, T., Kim, A., Cajigas-Du Ross, C. K., Ray, S., Huang, E., Taiwo, M., Arya, R., Wu, J., et al. (2023) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-031521-030435 · Cited by 289 · see citing works

Hepatic Injury in Nonalcoholic Steatohepatitis Contributes to Altered Intestinal Permeability

Luther, J., Garber, J. J., Khalili, H., Dave, M., Bale, S. S., Jindal, R., Motola, D. L., Luther, S., Bohr, S., Jeoung, S. W., et al. (2015) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2015.01.001 · Cited by 286 · see citing works

Alcoholic Liver Disease: The Gut Microbiome and Liver Cross Talk

Hartmann, P., Seebauer, C. T., & Schnabl, B. (2015) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.12704 · Cited by 282 · see citing works

The microbiota in cirrhosis and its role in hepatic decompensation

Trebicka, J., Macnaughtan, J., Schnabl, B., Shawcross, D. L., & Bajaj, J. S. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2020.11.013 · Cited by 276 · see citing works

Gastric acid suppression promotes alcoholic liver disease by inducing overgrowth of intestinal Enterococcus

Llorente, C., Jepsen, P., Inamine, T., Wang, L., Bluemel, S., Wang, H. J., Loomba, R., Bajaj, J. S., Schubert, M. L., Sikaroodi, M., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00796-x · Cited by 257 · see citing works

Methods to determine intestinal permeability and bacterial translocation during liver disease

Wang, L., Llorente, C., Hartmann, P., Yang, A.-M., Chen, P., & Schnabl, B. (2015) · Journal of Immunological Methods · doi:10.1016/j.jim.2014.12.015 · Cited by 257 · see citing works

Microbiome as a therapeutic target in alcohol-related liver disease

Sarin, S. K., Pande, A., & Schnabl, B. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.10.019 · Cited by 252 · see citing works

Intestinal Fungal Dysbiosis and Systemic Immune Response to Fungi in Patients With Alcoholic Hepatitis

Lang, S., Duan, Y., Liu, J., Torralba, M., Kuelbs, C., Cots, M. V., Abraldeṣ, J. G., Bosques‐Padilla, F., Verna, E. C., Brown, R. S., et al. (2019) · Hepatology · doi:10.1002/hep.30832 · Cited by 239 · see citing works

Therapeutic Targeting of Hepatic Macrophages for the Treatment of Liver Diseases

van der Heide, D., Weiskirchen, R., & Bansal, R. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02852 · Cited by 234 · see citing works

Developmental origins of NAFLD: a womb with a clue

Wesolowski, S. R., Kasmi, K. C. E., Jonscher, K. R., & Friedman, J. E. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.160 · Cited by 231 · see citing works

The Candida albicans exotoxin candidalysin promotes alcohol-associated liver disease

Chu, H., Duan, Y., Lang, S., Jiang, L., Wang, Y., Llorente, C., Liu, J., Mogavero, S., Bosques‐Padilla, F., Abraldeṣ, J. G., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.09.029 · Cited by 230 · see citing works

Gut–liver axis, cirrhosis and portal hypertension: the chicken and the egg

Arab, J. P., Martín‐Mateos, R., & Shah, V. H. (2017) · Hepatology International · doi:10.1007/s12072-017-9798-x · Cited by 229 · see citing works

Gut‐liver axis at the frontier of host‐microbial interactions

Brandl, K., Kumar, V., & Eckmann, L. (2017) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00361.2016 · Cited by 201 · see citing works

Commensal microbiota is hepatoprotective and prevents liver fibrosis in mice

Mazagova, M., Wang, L., Anfora, A. T., Wissmueller, M., Lesley, S. A., Miyamoto, Y., Eckmann, L., Dhungana, S., Pathmasiri, W., Sumner, S., et al. (2015) · The FASEB Journal · doi:10.1096/fj.14-259515 · Cited by 199 · see citing works

Recent advances in alcohol-related liver disease (ALD): summary of a Gut round table meeting

Avila, M., Dufour, J., Gerbes, A., Zoulim, F., Bataller, R., Burra, P., Cortez-Pinto, H., Gao, B., Gilmore, I., Mathurin, P., et al. (2019) · Gut · doi:10.1136/gutjnl-2019-319720 · Cited by 179 · see citing works

Microbiota tryptophan metabolism induces aryl hydrocarbon receptor activation and improves alcohol-induced liver injury

Wrzosek, L., Ciocan, D. M., Hugot, C., Spatz, M., Dupeux, M., Houron, C., Moal, V. L.-L., Puchois, V., Ferrere, G., Trainel, N., et al. (2020) · Gut · doi:10.1136/gutjnl-2020-321565 · Cited by 206 · see citing works

Tauroursodeoxycholic acid inhibits intestinal inflammation and barrier disruption in mice with non‐alcoholic fatty liver disease

Wang, W., Zhao, J., Gui, W., Sun, D., Dai, H., Xiao, L., Chu, H., Du, F., Zhu, Q., Schnabl, B., et al. (2017) · British Journal of Pharmacology · doi:10.1111/bph.14095 · Cited by 208 · see citing works

The Gut Microbiota and Liver Disease

Llorente, C., & Schnabl, B. (2015) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2015.04.003 · Cited by 189 · see citing works

Malnutrition in Patients with Liver Cirrhosis

Traub, J., Reiss, L., Aliwa, B. O., & Stadlbauer, V. (2021) · Nutrients · doi:10.3390/nu13020540 · Cited by 179 · see citing works

Gut microbiome, cognitive function and brain structure: a multi-omics integration analysis

Liang, X., Fu, Y., Cao, W., Wang, Z., Zhang, K., Jiang, Z., Jia, X., Liu, C., Lin, H.-R., Zhong, H., et al. (2022) · Translational Neurodegeneration · doi:10.1186/s40035-022-00323-z · Cited by 188 · see citing works

The link between inflammation, bugs, the intestine and the brain in alcohol dependence

Leclercq, S., de Timary, P., Delzenne, N. M., & Stärkel, P. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.15 · Cited by 174 · see citing works

Intestinal permeability, microbial translocation, changes in duodenal and fecal microbiota, and their associations with alcoholic liver disease progression in humans

Maccioni, L., Gao, B., Leclercq, S., Pirlot, B., Horsmans, Y., De Timary, P., Leclercq, I., Fouts, D., Schnabl, B., & Stärkel, P. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1782157 · Cited by 174 · see citing works

Intestinal Microbiota and Nonalcoholic Steatohepatitis

Brandl, K., & Schnabl, B. (2017) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000349 · Cited by 169 · see citing works

Natural acquisition and spontaneous elimination of Helicobacter pylori infection: clinical implications.

Xia, H. H. X., & Talley, N. J. (1997) · PubMed · Cited by 161 · see citing works

Role of Gut Dysbiosis in Liver Diseases: What Have We Learned So Far?

Fukui, H. (2019) · Diseases · doi:10.3390/diseases7040058 · Cited by 151 · see citing works

The Gut Barrier, Intestinal Microbiota, and Liver Disease: Molecular Mechanisms and Strategies to Manage

Plaza‐Díaz, J., Solis‐Urra, P., Rodríguez‐Rodríguez, F., Arancibia, J. E. O., Navarro-Oliveros, M., Abadía‐Molina, F., & Álvarez‐Mercado, A. I. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218351 · Cited by 147 · see citing works

Leukocytes, Systemic Inflammation and Immunopathology in Acute-on-Chronic Liver Failure

Casulleras, M., Zhang, I. W., López‐Vicario, C., & Clària, J. (2020) · Cells · doi:10.3390/cells9122632 · Cited by 137 · see citing works

Intestinal Immune Dysregulation Driven by Dysbiosis Promotes Barrier Disruption and Bacterial Translocation in Rats With Cirrhosis

Muñoz, L., Borrero, M., Cantera, M., Conde, E., del Campo, R., Rodríguez‐Serrano, M., Lario, M., Sánchez‐Díaz, A., Pastor, Ó., Díaz, D., et al. (2018) · Hepatology · doi:10.1002/hep.30349 · Cited by 134 · see citing works

Interactions between gut microbiota and non-alcoholic liver disease: The role of microbiota-derived metabolites

Ding, Y., Yanagi, K., Cheng, C., Alaniz, R. C., Lee, K., & Jayaraman, A. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.01.029 · Cited by 122 · see citing works

Enteric dysbiosis-linked gut barrier disruption triggers early renal injury induced by chronic high salt feeding in mice

Hu, J., Luo, H., Wang, J., Tang, W., Lu, J., Wu, S., Xiong, Z., Yang, G., Chen, Z., Lan, T., et al. (2017) · Experimental & Molecular Medicine · doi:10.1038/emm.2017.122 · Cited by 126 · see citing works

Changes in the Intestinal Microbiome and Alcoholic and Nonalcoholic Liver Diseases: Causes or Effects?

Betrapally, N. S., Gillevet, P. M., & Bajaj, J. S. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.073 · Cited by 123 · see citing works

Intestinal dysbiosis and permeability: the yin and yang in alcohol dependence and alcoholic liver disease

Stärkel, P., Leclercq, S., de Timary, P., & Schnabl, B. (2018) · Clinical Science · doi:10.1042/cs20171055 · Cited by 123 · see citing works

Reduced gut microbiome protects from alcohol-induced neuroinflammation and alters intestinal and brain inflammasome expression

Lowe, P., Gyöngyösi, B., Satishchandran, A., Iracheta‐Vellve, A., Cho, Y., Ambade, A., & Szabó, G. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1328-9 · Cited by 122 · see citing works

Alcoholic hepatitis: Translational approaches to develop targeted therapies

Mandrekar, P., Bataller, R., Tsukamoto, H., & Gao, B. (2016) · Hepatology · doi:10.1002/hep.28530 · Cited by 115 · see citing works

Ability of prebiotic polysaccharides to activate a HIF1α-antimicrobial peptide axis determines liver injury risk in zebrafish

Zhang, Z., Ran, C., Ding, Q., Liu, H.-L., Xie, M., Yang, Y., Xie, Y.-D., Gao, C., Zhang, H., & Zhou, Z. (2019) · Communications Biology · doi:10.1038/s42003-019-0526-z · Cited by 118 · see citing works

The Acute-on-Chronic Liver Failure Syndrome, or When the Innate Immune System Goes Astray

Clària, J., Arroyo, V., & Moreau, R. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600818 · Cited by 111 · see citing works

Microbiota Protects Mice Against Acute Alcohol‐Induced Liver Injury

Chen, P., Miyamoto, Y., Mazagova, M., Lee, K., Eckmann, L., & Schnabl, B. (2015) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.12900 · Cited by 111 · see citing works

Hyperuricemia is associated with impaired intestinal permeability in mice

Xu, D., Lv, Q., Wang, X., Cui, X., Zhao, P., Yang, X., Liu, X., Yang, W. Q., Yang, G., Wang, G., et al. (2019) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00151.2019 · Cited by 110 · see citing works

Sepsis in alcohol-related liver disease

Gustot, T., Fernández, J., Szabó, G., Albillos, A., Louvet, A., Jalan, R., Moreau, R., & Moreno, C. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.06.013 · Cited by 108 · see citing works

Alcohol and the Intestine

Patel, S., Behara, R., Swanson, G. B., Forsyth, C. B., Voigt, R. M., & Keshavarzian, A. (2015) · Biomolecules · doi:10.3390/biom5042573 · Cited by 108 · see citing works

Alcoholic Liver Disease: Update on the Role of Dietary Fat

Kirpich, I., Miller, M. E., Cave, M. C., Joshi‐Barve, S., & McClain, C. J. (2016) · Biomolecules · doi:10.3390/biom6010001 · Cited by 104 · see citing works

Fecal microbiota transplantation compared with prednisolone in severe alcoholic hepatitis patients: a randomized trial

Pande, A., Sharma, S., Khillan, V., Rastogi, A., Arora, V., Shasthry, S. M., Vijayaraghavan, R., Jagdish, R. K., Kumar, M., Kumar, G., et al. (2022) · Hepatology International · doi:10.1007/s12072-022-10438-0 · Cited by 100 · see citing works

Apoptosis of enterocytes and nitration of junctional complex proteins promote alcohol-induced gut leakiness and liver injury

Cho, Y.-E., Yu, L.-R., Abdelmegeed, M. A., Yoo, S.-H., & Song, B.-J. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.02.005 · Cited by 99 · see citing works

Biomarkers for oralization during long-term proton pump inhibitor therapy predict survival in cirrhosis

Horvath, A., Rainer, F., Bashir, M., Leber, B., Schmerboeck, B., Klymiuk, I., Groselj-Strele, A., Durdevic, M., Freedberg, D. E., Abrams, J. A., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-48352-5 · Cited by 93 · see citing works

Glutamate/metabotropic glutamate receptor-5 signaling in hepatic stellate cells drives endocannabinoid-mediated alcoholic steatosis

Choi, W.-M., Kim, H.-H., Kim, M.-H., Cinar, R., Yi, H.-S., Eun, H., Kim, S.-H., Choi, Y. J., Lee, Y.-S., Kim, S. Y., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.08.001 · Cited by 92 · see citing works

Probiotics and Alcoholic Liver Disease: Treatment and Potential Mechanisms

Li, F., Duan, K., Wang, C., McClain, C. J., & Feng, W. (2015) · Gastroenterology Research and Practice · doi:10.1155/2016/5491465 · Cited by 97 · see citing works

Saturated and Unsaturated Dietary Fats Differentially Modulate Ethanol-Induced Changes in Gut Microbiome and Metabolome in a Mouse Model of Alcoholic Liver Disease

Kirpich, I., Petrosino, J. F., Ajami, N. J., Feng, W., Wang, Y., Liu, Y., Beier, J. I., Barve, S. S., Yin, X., Wei, X., et al. (2016) · American Journal Of Pathology · doi:10.1016/j.ajpath.2015.11.017 · Cited by 95 · see citing works

The study evaluating the effect of probiotic supplementation on the mental status, inflammation, and intestinal barrier in major depressive disorder patients using gluten-free or gluten-containing diet (SANGUT study): a 12-week, randomized, double-blind, and placebo-controlled clinical study protocol

Karakuła‐Juchnowicz, H., Róg, J., Juchnowicz, D., Łoniewski, I., Skonieczna‐Żydecka, K., Krukow, P., Futyma-Jędrzejewska, M., & Kaczmarczyk, M. (2019) · Nutrition Journal · doi:10.1186/s12937-019-0475-x · Cited by 93 · see citing works

Microbiota, Obesity and NAFLD

Lau, L. H. S., & Wong, S. H. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-8684-7_9 · Cited by 91 · see citing works

Innate lymphocytes: pathogenesis and therapeutic targets of liver diseases and cancer

Chen, Y.-Y., & Tian, Z. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-00561-z · Cited by 83 · see citing works

Reduced microbial diversity in adult survivors of childhood acute lymphoblastic leukemia and microbial associations with increased immune activation

Chua, L. L., Rajasuriar, R., Azanan, M. S., Abdullah, N. K., Tang, M. S., Lee, S. C., Woo, Y. L., Lim, Y. A. L., Ariffin, H., & Loke, P. (2017) · Microbiome · doi:10.1186/s40168-017-0250-1 · Cited by 90 · see citing works

Alcohol, microbiome, and their effect on psychiatric disorders

Hillemacher, T., Bachmann, O. P., Kahl, K. G., & Frieling, H. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.04.015 · Cited by 87 · see citing works

Gut inflammation exacerbates hepatic injury in the high-fat diet induced NAFLD mouse: Attention to the gut-vascular barrier dysfunction

Cheng, C., Tan, J., Qian, W., Zhang, L., & Hou, X. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.08.017 · Cited by 86 · see citing works

Precision medicine in alcoholic and nonalcoholic fatty liver disease via modulating the gut microbiota

Bluemel, S., Williams, B., Knight, R. D., & Schnabl, B. (2016) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00245.2016 · Cited by 83 · see citing works

Is intestinal inflammation linking dysbiosis to gut barrier dysfunction during liver disease?

Brandl, K., & Schnabl, B. (2015) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2015.1057122 · Cited by 82 · see citing works

A role for the peripheral immune system in the development of alcohol use disorders?

de Timary, P., Stärkel, P., Delzenne, N. M., & Leclercq, S. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.04.013 · Cited by 80 · see citing works

Commensal Lactobacillus Controls Immune Tolerance during Acute Liver Injury in Mice

Nakamoto, N., Amiya, T., Aoki, R., Taniki, N., Koda, Y., Miyamoto, K., Teratani, T., Suzuki, T., Chiba, S., Chu, P., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.10.022 · Cited by 79 · see citing works

The circadian disruption of night work alters gut microbiota consistent with elevated risk for future metabolic and gastrointestinal pathology

Mortaş, H., Bilici, S., & Karakan, T. (2020) · Chronobiology International · doi:10.1080/07420528.2020.1778717 · Cited by 78 · see citing works

Healing the diabetic wound: Unlocking the secrets of genes and pathways

Kamal, R., Awasthi, A., Pundir, M., & Thakur, S. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176645 · Cited by 78 · see citing works

Intrahepatic microbes govern liver immunity by programming NKT cells

Leinwand, J., Paul, B., Chen, R., Xu, F., Sierra, M. A., Paluru, M. M. R., Nanduri, S., Hirsch, C. A., Shadaloey, S. A. A., Yang, F., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci151725 · Cited by 79 · see citing works

Gut microbiota dysbiosis: The potential mechanisms by which alcohol disrupts gut and brain functions

Chen, G., Shi, F., Yin, W., Guo, Y., Liu, A., Shuai, J., & Sun, J. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.916765 · Cited by 77 · see citing works

Sea buckthorn ( Hippophae rhamnoides L.) fermentation liquid protects against alcoholic liver disease linked to regulation of liver metabolome and the abundance of gut microbiota

Ran, B., Guo, C., Li, W., Li, W., Wáng, Q., Qian, J., & Li, H. (2020) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.10915 · Cited by 76 · see citing works

Propionate Ameliorates Alcohol-Induced Liver Injury in Mice via the Gut–Liver Axis: Focus on the Improvement of Intestinal Permeability

Xu, Q., Zhang, R., Mu, Y., Song, Y., Hao, N., Wei, Y., Wang, Q., & Mackay, C. R. (2022) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.2c00633 · Cited by 76 · see citing works

Gut microbiota in liver disease: too much is harmful, nothing at all is not helpful either

Hartmann, P., Chu, H., Duan, Y., & Schnabl, B. (2019) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00370.2018 · Cited by 73 · see citing works

Protective Effects of Ellagic Acid Against Alcoholic Liver Disease in Mice

Zhao, L., Mehmood, A., Soliman, M. M., Iftikhar, A., Iftikhar, M., Aboelenin, S. M., & Wang, C. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.744520 · Cited by 74 · see citing works

Faeces‐derived extracellular vesicles participate in the onset of barrier dysfunction leading to liver diseases

Fizanne, L., Villard, A., Benabbou, N., Recoquillon, S., Soleti, R., Delage, E., Wertheimer, M., Vidal‐Gómez, X., Oullier, T., Chaffron, S., et al. (2023) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12303 · Cited by 73 · see citing works

Gut-liver axis: Recent concepts in pathophysiology in alcohol-associated liver disease

Raya Tonetti, F., Eguileor, A., Mrdjen, M., Pathak, V., Travers, J., Nagy, L. E., & Llorente, C. (2024) · Hepatology · doi:10.1097/hep.0000000000000924 · Cited by 78 · see citing works

Gut microbiota in non‐alcoholic fatty liver disease and alcohol‐related liver disease: Current concepts and perspectives

Arab, J. P., Arrese, M. A., & Shah, V. H. (2019) · Hepatology Research · doi:10.1111/hepr.13473 · Cited by 72 · see citing works

Combined alcoholic and non-alcoholic steatohepatitis

Wandji, L. C. N., Gnemmi, V., Mathurin, P., & Louvet, A. (2020) · JHEP Reports · doi:10.1016/j.jhepr.2020.100101 · Cited by 70 · see citing works

The gut–liver axis in immune remodeling of hepatic cirrhosis

Guan, H., Zhang, X., Kuang, M., & Yu, J. Q. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.946628 · Cited by 69 · see citing works

Alcohol-associated bowel disease: new insights into pathogenesis

Maccioni, L., Fu, Y., Horsmans, Y., Leclercq, I., Stärkel, P., Kunos, G., & Gao, B. (2023) · eGastroenterology · doi:10.1136/egastro-2023-100013 · Cited by 69 · see citing works

Publisher Correction: The gut–liver axis and the intersection with the microbiome

Tripathi, A., Debelius, J., Brenner, D. A., Karin, M., Loomba, R., Schnabl, B., & Knight, R. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0031-8 · Cited by 68 · see citing works

Role of the adaptive immune system in diabetic kidney disease

Kong, L., Andrikopoulos, S., MacIsaac, R. J., Mackay, L. K., Nikolic‐Paterson, D. J., Torkamani, N., Zafari, N., Marin, E. C. S., & Ekinci, E. I. (2021) · Journal of Diabetes Investigation · doi:10.1111/jdi.13725 · Cited by 65 · see citing works

Alcoholic Liver Disease: Role of Cytokines

Neuman, M. G., Maor, Y., Nanau, R. M., Melzer, E., Mell, H., Opris, M., Cohen, L. B., & Malnick, S. D. H. (2015) · Biomolecules · doi:10.3390/biom5032023 · Cited by 67 · see citing works

Endogenous ethanol production in health and disease

Meijnikman, A. S., Nieuwdorp, M., & Schnabl, B. (2024) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-024-00937-w · Cited by 65 · see citing works

Transcriptional and Epigenetic Regulation of Monocyte and Macrophage Dysfunction by Chronic Alcohol Consumption

Malherbe, D. C., & Messaoudi, I. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.911951 · Cited by 64 · see citing works

Gut‐liver axis: Potential mechanisms of action of food‐derived extracellular vesicles

Zhang, S., Wang, Q., Tan, D. E. L., Sikka, V., Ng, C. H., Xian, Y., Li, D., Muthiah, M. D., Chew, N., Storm, G., et al. (2024) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12466 · Cited by 62 · see citing works

The Role of Gut Microbiota and Leaky Gut in the Pathogenesis of Food Allergy

Poto, R., Fusco, W., Rinninella, E., Cintoni, M., Kaitsas, F., Raoul, P. C., Caruso, C., Mele, M. C., Varricchi, G., Gasbarrini, A., et al. (2023) · Nutrients · doi:10.3390/nu16010092 · Cited by 67 · see citing works

Gut dysbiosis breaks immunological tolerance toward the central nervous system during young adulthood

Yadav, S. K., Boppana, S., Ito, N., Mindur, J. E., Mathay, M., Patel, A. H., Dhib-Jalbut, S. S., & Ito, K. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1615715114 · Cited by 61 · see citing works

Interleukin-17 in Liver Disease Pathogenesis

Li, N., Yamamoto, G., Fuji, H., & Kisseleva, T. (2021) · Seminars in Liver Disease · doi:10.1055/s-0041-1730926 · Cited by 64 · see citing works

Targeting Dysbiosis for the Treatment of Liver Disease

Anand, G. S., Zarrinpar, A., & Loomba, R. S. (2016) · Seminars in Liver Disease · doi:10.1055/s-0035-1571276 · Cited by 58 · see citing works

The gut microbiota: A new target in the management of alcohol dependence?

Leclercq, S., Stärkel, P., Delzenne, N. M., & de Timary, P. (2018) · Alcohol · doi:10.1016/j.alcohol.2018.03.005 · Cited by 60 · see citing works

Starring role of toll-like receptor-4 activation in the gut-liver axis

Carotti, S. (2015) · World Journal of Gastrointestinal Pathophysiology · doi:10.4291/wjgp.v6.i4.99 · Cited by 57 · see citing works

Proton pump inhibitor use increases mortality and hepatic decompensation in liver cirrhosis

Roza, M. A. D., Kai, L., Kam, J. W., Chan, Y. H., Kwek, A. B. E., Ang, T. L., & Hsiang, J. C. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i33.4933 · Cited by 56 · see citing works

Tumor necrosis factor alpha‐induced receptor 1 signaling in alcoholic liver disease: A gut reaction?

Barve, S. S., Kirpich, I., & McClain, C. J. (2014) · Hepatology · doi:10.1002/hep.27640 · Cited by 4 · see citing works

Intestinal HIF‐1α Deletion Exacerbates Alcoholic Liver Disease through Inducing Intestinal Dysbiosis and Barrier Dysfunction

Feng, W. (2019) · The FASEB Journal · doi:10.1096/fasebj.2019.33.1_supplement.821.9 · Cited by 1 · see citing works

Intestinal HIF-1α deletion exacerbates alcoholic liver disease by inducing intestinal dysbiosis and barrier dysfunction

Shao, T., Zhao, C., Li, F., Gu, Z., Liu, L., Zhang, L., Wang, Y., He, L., Liu, Y., Liu, Q., et al. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.05.021 · Cited by 258 · see citing works

Intestinal barrier disfunction and endotoxemia – links in the inflammatory cascade in alcoholic liver disease

Kasztelan‐Szczerbińska, B., Słomka, M., & Celiński, K. (2010) · Gastroenterology Review · doi:10.5114/pg.2010.14034 · Cited by 1 · see citing works

Intestinal fungi fuel the inflammatory fire in alcoholic liver disease

Thomas, H. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.78 · Cited by 10 · see citing works